Head-to-head
Ro vs Hims & Hers
Ro and Hims & Hers both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Ro
Ranked #5 · Grade B
Best for: Parents who specifically want brand-name medication and insurance help, and will trade a fast, price-first decision for a bigger clinical apparatus.
Visit RoHims & Hers
Higher scoreRanked #4 · Grade B+
Best for: Parents who want a recognizable, app-driven brand with a quick async signup and clear semaglutide pricing.
Visit Hims & HersThe verdict
Hims & Hers edges out Ro on the Rx-Readiness Score, 87 to 86 (B+ vs B). Parents who want a recognizable, app-driven brand with a quick async signup and clear semaglutide pricing.
Ro is still a genuine option — a heavyweight platform with brand-name access and insurance navigation — powerful if you want FDA-approved product, but the compounded pricing is opaque and can slow a quick decision. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Ro | Hims & Hers |
|---|---|---|
| Rx-Readiness Score | 86/100 · B | 87/100 · B+ |
| Overall rank | #5 | #4 |
| Semaglutide | Not disclosed | $199/mo |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Multi-state | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Ro
Ranked #5 · Grade B
What we like
- Brand-name (Wegovy/Zepbound) access plus insurance navigation
- Oral options and a well-funded, polished platform
- Deep clinical infrastructure for a more involved path
The caveats
- Compounded pricing isn't posted up front — hard to compare fast
- Insurance and brand routes add steps, not speed
- Premium positioning overall
Hims & Hers
Ranked #4 · Grade B+
What we like
- Slick app-first experience with a fast, mostly async intake
- Flat, posted semaglutide pricing and nationwide coverage
- Well-known operator with a mature support stack
The caveats
- Tirzepatide pricing isn't consistently disclosed up front
- Compounded only — no brand or oral route
- Upsells across a broad catalog can add noise to a simple decision
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Ro and Hims & Hers against other providers on our shortlist.
Or browse the full comparison hub.